Long-Term Persistence and Relevant Therapeutic Impact of High-Titer Viral-Neutralizing Antibody in a Convalescent COVID-19 Plasma Super-Donor: A Case Report
A convalescent, non-severe, patient with COVID-19 was enrolled as a hyper-immune plasma voluntary donor by the Immuno-Hematology and Transfusion Unit of the Regina Elena National Cancer Institute in Rome, under the TSUNAMI national study criteria. During a nearly 6-month period (May–October 2020), t...
Main Authors: | Mafalda De Rienzo, Maria Laura Foddai, Laura Conti, Chiara Mandoj, Stefano Iaboni, Ilenia Saladini, Concetta Castilletti, Giulia Matusali, Davide Roberto Donno, Luisa Marchioni, Stefania Ianniello, Angela Corpolongo, Maria Palange, Gennaro Ciliberto, Giulia Piaggio, Federico De Marco |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.690322/full |
Similar Items
-
Therapeutic Immunoglobulin Selected For High Antibody Titer to RSV Also Contains High Antibody Titers to Other Respiratory Viruses
by: Jordan eOrange
Published: (2015-08-01) -
Convalescent Plasma for the Treatment of Severe COVID-19
by: Franchini M, et al.
Published: (2021-02-01) -
Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review
by: Massimo Franchini, et al.
Published: (2021-06-01) -
The Three Pillars of COVID-19 Convalescent Plasma Therapy
by: Massimo Franchini, et al.
Published: (2021-04-01) -
Development of an ELISA for distinguishing convalescent sera with Mycoplasma hyopneumoniae infection from hyperimmune sera responses to bacterin vaccination in pigs
by: Honglei Ding, et al.
Published: (2021-09-01)